Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the Company has won a competitive contract for 18 QS-H150s to be shipped to a county in the EMEA region ( Europe , the Middle East and Africa ). The country which made the purchase is a North Atlantic Treaty Alliance (NATO) member nation and will use Implant Sciences' handheld explosive trace detectors in military applications.
"Our sales team has done a great job of getting the QS-H150 in front of this important customer for a sizeable contact. Ultimately, based on feedback from the customer, we believe that Implant Sciences was awarded this contract due to the outstanding performance of our QS-H150. In a direct, side by side comparison, our handheld device proved superior over competing systems in detecting trace levels of a range of explosives," stated Implant Sciences' Vice President of Global Sales and Marketing, Dr. Darryl Jones . "We're proud of the consistent, high performance capabilities of our explosives trace detectors."
About the QS-H150 Handheld Explosives Trace Detector
The QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.
Source: Implant Sciences Corporation
Date: Nov 24, 2014